AGIOS PHARMACEUTICALS, INC.·4

May 18, 4:11 PM ET

Miles Darrin 4

4 · AGIOS PHARMACEUTICALS, INC. · Filed May 18, 2021

Insider Transaction Report

Form 4
Period: 2021-05-14
Miles Darrin
Chief Commercial Officer
Transactions
  • Sale

    Common stock

    2021-05-14$55.41/sh3,462$191,8297,209 total
Footnotes (1)
  • [F1]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.40 to $55.47. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    wf-form4_162136864414651.xmlPrimary

    FORM 4